Human dendritic cells transfected with a human papilloma virus-18 construct display decreased mobility and upregulated cytokine production

International Journal of Oncology

Volumn 43, Issue 5, 2013, Pages 1701-1709

  Khaiboullina, Svetlana F ^a,e   Morzunov, Sergey P ^b   Hall, Mark R ^b   De Meirleir, Kenny L ^c   Rizvanov, Albert A ^d   Lombardi, Vincent C ^a,e  

^a UNIVERSITY OF NEVADA   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^e Whittemore Peterson Institute   (United States)

Author keywords

Cytokine; Dendritic cell; Mobility; Papillomavirus

Indexed keywords

CAPSID PROTEIN; PROTEIN E6; PROTEIN E7;

ARTICLE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VIRUS GENOME;

APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; CERVIX UTERI; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; FORESKIN; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOPRECIPITATION; MALE; PAPILLOMAVIRUS INFECTIONS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 84885079691     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2074     Document Type: Article

References (54)

1. zur Hausen H: Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288: F55-F78, 1996.
2. Kanodia S, Fahey LM and Kast WM: Mechanisms used by human papillomaviruses to escape the host immune response. Curr Cancer Drug Targets 7: 79-89, 2007.
3. Frazer IH: The role of the immune system in anogenital human papillomavirus. Australas J Dermatol 39 (Suppl 1): S5-S7, 1998.
4. al-Saleh W, Giannini SL, Jacobs N, et al: Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J Pathol 184: 283-290, 1998.
5. Coleman N, Birley HD, Renton AM, et al: Immunological events in regressing genital warts. Am J Clin Pathol 102: 768-774, 1994.
6. al-Saleh W, Delvenne P, Arrese JE, Nikkels AF, Pierard GE and Boniver J: Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch 427: 41-48, 1995.
7. McArdle JP and Muller HK: Quantitative assessment of Langerhans' cells in human cervical intraepithelial neoplasia and wart virus infection. Am J Obstet Gynecol 154: 509-515, 1986.
8. Morelli AE, Sananes C, Di Paola G, Paredes A and Fainboim L: Relationship between types of human papillomavirus and Langerhans' cells in cervical condyloma and intraepithelial neoplasia. Am J Clin Pathol 99: 200-206, 1993.
9. Morris HH, Gatter KC, Stein H and Mason DY: Langerhans' cells in human cervical epithelium: an immunohistological study. Br J Obstet Gynaecol 90: 400-411, 1983.
10. Viac J, Guerin-Reverchon I, Chardonnet Y and Bremond A: Langerhans cells and epithelial cell modifications in cervical intraepithelial neoplasia: correlation with human papillomavirus infection. Immunobiology 180: 328-338, 1990.
11. Abbas AK, Lichtman AH and Pober JS: Cellular and Molecular Immunology. Saunders, Philadelphia, PA, 1997.
12. Breathnach SM: The Langerhans cell. Br J Dermatol 119: 463-469, 1988.
13. Melief CJ: Dendritic cells as specialized antigen-presenting cells. Res Immunol 140: 902-906; discussion 918-926, 1989.
14. Mota F, Rayment N, Chong S, Singer A and Chain B: The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin Exp Immunol 116: 33-40, 1999.
15. Hubert P, van den Brule F, Giannini SL, Franzen-Detrooz E, Boniver J and Delvenne P: Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. Am J Pathol 154: 775-784, 1999.
16. Arany I, Goel A and Tyring SK: Interferon response depends on viral transcription in human papillomavirus-containing lesions. Anticancer Res 15: 2865-2869, 1995.
17. Park JS, Kim EJ, Kwon HJ, Hwang ES, Namkoong SE and Um SJ: Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 275: 6764-6769, 2000.
18. Evander M, Frazer IH, Payne E, Qi YM, Hengst K and McMillan NA: Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 71: 2449-2456, 1997.
19. Price AA, Cumberbatch M, Kimber I and Ager A: Alpha 6 integrins are required for Langerhans cell migration from the epidermis. J Exp Med 186: 1725-1735, 1997.
20. Bonnez W, Reichman RC, Strussenberg J and Roberts NJ Jr: In vitro interactions between bovine papillomavirus and human monocytes and macrophages. Intervirology 32: 246-252, 1991.
21. Tagami H, Oguchi M and Ofuji S: The phenomenon of spontaneous regression of numerous flat warts: immunohistological studies. Cancer 45: 2557-2563, 1980.
22. Beutner KR and Tyring S: Human papillomavirus and human disease. Am J Med 102: 9-15, 1997.
23. Shah KV and Howley PM: Papillomaviruses. In: B.N. Fields, D.M. Knipe and M. Howley (eds.), Fields Virology, 3rd edition. Lippincott-Raven Publishers, Philadelphia, PA, pp2077-2109, 1996.
24. Le Buanec H, D'Anna R, Lachgar A, et al: HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes. Biomed Pharmacother 53: 424-431, 1999.
25. Carter JJ, Koutsky LA, Hughes JP, et al: Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 181: 1911-1919, 2000.
26. Lin YL, Borenstein LA, Selvakumar R, Ahmed R and Wettstein FO: Progression from papilloma to carcinoma is accompanied by changes in antibody response to papillomavirus proteins. J Virol 67: 382-389, 1993.
27. Park JS, Park DC, Kim CJ, et al: HPV-16-related proteins as the serologic markers in cervical neoplasia. Gynecol Oncol 69: 47-55, 1998.
28. Steele JC and Gallimore PH: Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1. Virology 174: 388-398, 1990.
29. Suzich JA, Ghim SJ, Palmer-Hill FJ, et al: Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA 92: 11553-11557, 1995.
30. Frazer IH, Thomas R, Zhou J, et al: Potential strategies utilised by papillomavirus to evade host immunity. Immunol Rev 168: 131-142, 1999.
31. Rosl F, Lengert M, Albrecht J, et al: Differential regulation of the JE gene encoding the monocyte chemoattractant protein (MCP-1) in cervical carcinoma cells and derived hybrids. J Virol 68: 2142-2150, 1994.
32. Santin AD, Hermonat PL, Ravaggi A, et al: Development, characterization and distribution of adoptively transferred peripheral blood lymphocytes primed by human papillomavirus 18 E7 - pulsed autologous dendritic cells in a patient with metastatic adenocarcinoma of the uterine cervix. Eur J Gynaecol Oncol 21: 17-23, 2000.
33. Carlson MW, Iyer VR and Marcotte EM: Quantitative gene expression assessment identifies appropriate cell line models for individual cervical cancer pathways. BMC Genomics 8: 117, 2007.
34. Miyasaka M, Takami Y, Inoue H and Hakura A: Rat primary embryo fibroblast cells suppress transformation by the E6 and E7 genes of human papillomavirus type 16 in somatic hybrid cells. J Virol 65: 479-482, 1991.
35. Yutsudo M, Okamoto Y and Hakura A: Functional dissociation of transforming genes of human papillomavirus type 16. Virology 166: 594-597, 1988.
36. Cumberbatch M, Dearman RJ and Kimber I: Constitutive and inducible expression of interleukin-6 by Langerhans cells and lymph node dendritic cells. Immunology 87: 513-518, 1996.
37. Saitoh A, Yasaka N, Osada A, Nakamura K, Furue M and Tamaki K: Migration of Langerhans cells in an in vitro organ culture system: IL-6 and TNF-alpha are partially responsible for migration into the epidermis. J Dermatol Sci 19: 166-174, 1999.
38. Stoitzner P, Zanella M, Ortner U, et al: Migration of langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF-alpha and IL-1beta. J Leukoc Biol 66: 462-470, 1999.
39. Hope JC, Cumberbatch M, Fielding I, Dearman RJ, Kimber I and Hopkins SJ: Identification of dendritic cells as a major source of interleukin-6 in draining lymph nodes following skin sensitization of mice. Immunology 86: 441-447, 1995.
40. Gibran NS, Ferguson M, Heimbach DM and Isik FF: Monocyte chemoattractant protein-1 mRNA expression in the human burn wound. J Surg Res 70: 1-6, 1997.
41. Shreedhar V, Giese T, Sung VW and Ullrich SE: A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 160: 3783-3789, 1998.
42. Mantovani A, Bottazzi B, Colotta F, Sozzani S and Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270, 1992.
43. Miller MD and Krangel MS: Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12: 17-46, 1992.
44. Muller WA and Randolph GJ: Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J Leukoc Biol 66: 698-704, 1999.
45. Kleine K, Konig G, Kreuzer J, Komitowski D, Zur Hausen H and Rosl F: The effect of the JE (MCP-1) gene, which encodes monocyte chemoattractant protein-1, on the growth of HeLa cells and derived somatic-cell hybrids in nude mice. Mol Carcinog 14: 179-189, 1995.
46. Braun L, Durst M, Mikumo R, Crowley A and Robinson M: Regulation of growth and gene expression in human papillomavirus-transformed keratinocytes by transforming growth factor-beta: implications for the control of papillomavirus infection. Mol Carcinog 6: 100-111, 1992.
47. Ozbun MA and Meyers C: Transforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes. J Virol 70: 5437-5446, 1996.
48. Borkowski TA, Letterio JJ, Farr AG and Udey MC: A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med 184: 2417-2422, 1996.
49. Geissmann F, Prost C, Monnet JP, Dy M, Brousse N and Hermine O: Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells. J Exp Med 187: 961-966, 1998.
50. Sato K, Kawasaki H, Nagayama H, et al: TGF-beta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors. J Immunol 164: 2285-2295, 2000.
51. Strobl H and Knapp W: TGF-beta1 regulation of dendritic cells. Microbes Infect 1: 1283-1290, 1999.
52. Nunez R, Sanchez M, Wild P, Filgueira L and Nunez C: Characterisation of two human dendritic cell-lines that express CD1a, take-up, process and present soluble antigens and induce MLR. Immunol Lett 61: 33-43, 1998.
53. Cole ST and Danos O: Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J Mol Biol 193: 599-608, 1987.
54. Dunzendorfer S, Kaser A, Meierhofer C, Tilg H and Wiedermann CJ: Dendritic cell migration in different micropore filter assays. Immunol Lett 71: 5-11, 2000.